Table 1.
Tumor Type | Detection | Expression | Correlate to Lymph Angiogenesis | Correlate to Lymph Node Metastasis | Ref. |
---|---|---|---|---|---|
Urothelial cancer | IHC | Tumor cells | − | − | [53] |
Breast cancer | IHC, RT-PCR, Western blot | Tumor cells | − | + | [54,55,56] |
Lung cancer | IHC, qRT-PCR, Western blot | Tumor cells | − | + | [57,58] |
Ovarian cancer | qRT-PCR, IHC, Western blot | Tumor cells | + | + | [59,60] |
Renal cell cancer | IHC | Tumor cells | − | + | [61,62,63] |
Endometrial cancer | IHC, qRT-PCR, Western blot | Tumor cells | − | + | [64,65] |
Colorectal cancer | IHC, qRT-PCR, Western blot | Tumor cells | + | + | [66,67,68] |
Gastric cancer | IHC, qRT-PCR | Tumor cells | + | + | [69,70] |
Bladder cancer | Western blot | Tumor cells | − | − | [71] |
Oral cancer | IHC | Tumor cells | + | + | [72] |
Head and neck cancer | qRT-PCR, qMSP-PCR | Tumor cells | − | − | [73] |
Esophageal cancer | IHC | Tumor cells | − | − | [74,75] |
Cervical cancer | IHC, in situ hybridization, qRT-PCR, Western blot |
Tumor cells | + | + | [76,77] |
Prostate cancer | IHC, in situ hybridization, qRT-PCR | Tumor cells | + | + | [78,79] |
Thyroid cancer | IHC | Tumor cells | − | − | [80,81] |
Pancreatic cancer | Western blot | Tumor cells | + | + | [82,83] |
Neuroblastoma | RT-PCR, Western blot | Tumor cells | − | − | [84,85] |
Melanoma | Western blot, IHC | Tumor cells | + | − | [86,87] |
Glioblastoma | In situ hybridization, qRT-PCR | Tumor cells | − | − | [88,89] |
Osteosarcoma | IHC | Tumor cells | − | − | [90] |
Laryngeal cancer | RT-PCR | Tumor cells | + | − | [91] |
Basal cell carcinoma | qRT-PCR, Western blot | Tumor cells | − | + | [92] |
Acute myeloid leukemia | RT-PCR, IHC | Acute myeloid leukemia (AML) natural killer (NK) cells | − | − | [93] |
+, the expression of VEGFR3 is correlated with angiogenesis or lymph node metastasis; −, the expression of VEGFR3 is not correlated with angiogenesis or lymph node metastasis.